INDOCO REMEDIES LIMITED
Location
Maharashtra
Founded
1947-08-23
Website
Risk Signals
87 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Medicinal Chemicals and Botanical Products, Pharmaceutical Preparations), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about INDOCO REMEDIES LIMITED
Live alerts from global media, monitored by Business Radar
2023-10-20 (equitypandit.com)
Indoco Remedies Shares Plummet 4% on Receiving 4 Observations for Goa Facility -
Shares of Indoco Remedies were trading 4% below on 20 October after the USFDA issued four observations for its Goa Facility.
Read more
2021-03-11 (biospace.com)
Sagent Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of Phenylephrine Hydrochloride Injection, USP, 10 mg/mL Due to Potential Lack of Sterility Assurance -
Sagent Pharmaceuticals, Inc. today announced the voluntary nationwide recall of three lots of Phenylephrine Hydrochloride Injection, USP (10 mg/mL)
Read more
(medicaldialogues.in)
Indoco Remedies bags tenders worth Rs 140 crore for Allopurinol Tablets in Germany
Mumbai: Indoco Remedies has recently announced that the company won major tenders worth Rs. 140 cr. in Germany, including the AOK for Allopurinol Tablets. The revenue expected from this business is...
Read more